Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Help 4 HD News Channel ~ AAN Update

  • Broadcast in News



Follow This Show

If you liked this show, you should follow Help4HD.

Wednesday, August 8, 2012

In direct response to previous shows and information disseminated about the AAN (the American Academy of Neurology) guidelines for treating chorea in Huntington's, Melissa Armstrong, MD, MSc and Gary Gronseth, MD, FAAN are here today to explain how the AAN Clinical Practice Guideline process works to deliver the best evidence-based recommendations to physicians who are treating for neurological disorders, in particular Huntington's disease. 
About the AAN
The American Academy of Neurology (AAN), established in 1948, is an international professional association of more than 25,000 neurologists and neuroscience professionals dedicated to promoting the highest quality patient-centered neurologic care.
Gary S Gronseth, MD, FAAN
Dr. Gronseth is a Professor of Neurology at the University of Kansas and has been involved with patient care and medical education for 25 years. Dr Gronseth is also the evidence-based medicine (EBM) methodologist for the American Academy of Neurology (AAN). He oversees many EBM projects of the AAN including the development of clinical practice guidelines for 18 years.

Melissa J Armstrong, MD, MSc
Dr. Armstrong is an Assistant Professor of Neurology at the University of Maryland School of Medicine is fellowship-trained in movement disorders and has a master’s degree in health care research from the University of Toronto. She cares for patients at the University of Maryland Parkinson’s Disease and Movement Disorders Center, participates in medical research and has been involved in guideline development for the American Academy of Neurology (AAN) since 2006, first as an author and now also as a member of the Guideline Development Subcommittee.